Smith S L, Bender J G, Berger C, Lee W J, Loudovaris M, Martinson J A, Opotowsky J D, Qiao X, Schneidkraut M, Sweeney P, Unverzagt K L, Van Epps D E, Williams D E, Williams S F, Zimmerman T M
University of Chicago, Department of Medicine, IL 60637, USA.
J Hematother. 1997 Aug;6(4):323-34. doi: 10.1089/scd.1.1997.6.323.
Bone marrow (BM) or peripheral blood (PB) CD34+ cells were cultured for 12 days in serum-free culture medium containing PIXY321 (IL-3/ GM-CSF fusion protein) with or without periodic supplements of granulocyte-colony stimulating factor (G-CSF). The cultures were evaluated at day 12 for total cell proliferation (fold increase from day 0), neutrophil differentiation by flow cytometry, using dual staining with CD15-FITC and CD11b-PE, and morphology using Wright-Giemsa and granule staining. In cultures containing PIXY321 where 6000 U/ml of G-CSF was added days 0 and 6, there was no significant difference (p > or = 0.05) in cell proliferation or the percent of CD15+/CD11b+ cells when compared with cultures with PIXY321 alone. ELISA analysis showed G-CSF levels had declined by 90% after 3 days of culture. Further studies were performed to assess the benefit of supplementing lower concentrations of G-CSF (600 U/ml) at more frequent intervals. A significant increase (p < or = 0.05) in cell proliferation and percent CD15+/CD11b+ was observed when G-CSF was added on days 0, 3, 6, and 9 (every 3 days) as compared with those cultures with PIXY321 alone. CD34+ cell proliferation without G-CSF was 19.6 +/- 4.8-fold, with G-CSF added on days 0 and 6 was 28.7 +/- 6.4-fold, and with G-CSF added on days 0, 3, 6, and 9 was 45.9 +/- 10.6-fold. Percent of CD15+/CD11b+ cells was 19.0 +/- 4.6%, 38.2 +/- 7.2%, and 58.5 +/- 6.5%, respectively, in these cultures. We observed more CD15+/CD11b+ cells, myelocytes/metamyelocytes, and secondary granule staining in cultures with G-CSF added on day, 0, 3, 6, and 9 as compared with cultures with G-CSF added on days 0 and 6 or no G-CSF added. We conclude that PIXY321 and G-CSF act synergistically on the in vitro proliferation and neutrophil differentiation of BM and PB CD34+ cells and that frequent supplements of G-CSF facilitate neutrophil differentiation.
将骨髓(BM)或外周血(PB)中的CD34 +细胞在含有PIXY321(IL - 3/GM - CSF融合蛋白)的无血清培养基中培养12天,培养基中添加或不添加粒细胞集落刺激因子(G - CSF)。在第12天对培养物进行评估,评估总细胞增殖情况(相对于第0天的增加倍数),通过流式细胞术使用CD15 - FITC和CD11b - PE双重染色评估中性粒细胞分化情况,并使用瑞氏 - 吉姆萨染色和颗粒染色评估形态学。在含有PIXY321且在第0天和第6天添加6000 U/ml G - CSF的培养物中,与仅含有PIXY321的培养物相比,细胞增殖或CD15 + /CD11b +细胞百分比无显著差异(p≥0.05)。ELISA分析显示,培养3天后G - CSF水平下降了90%。进行了进一步研究以评估更频繁地添加较低浓度G - CSF(600 U/ml)的益处。与仅含有PIXY321的培养物相比,当在第0天、第3天、第6天和第9天(每3天)添加G - CSF时,观察到细胞增殖和CD15 + /CD11b +百分比显著增加(p≤0.05)。不添加G - CSF时CD34 +细胞增殖为19.6±4.8倍,在第0天和第6天添加G - CSF时为28.7±6.4倍,在第0天、第3天、第6天和第9天添加G - CSF时为45.9±10.6倍。在这些培养物中,CD15 + /CD11b +细胞百分比分别为19.0±4.6%、38.2±7.2%和58.5±6.5%。与在第0天和第6天添加G - CSF或不添加G - CSF的培养物相比,我们观察到在第0天、第3天